Sciatica Treatment Market Size, Share, Growth Analysis, By Drug class(Non-steroidal anti-inflammatory drugs, Steroids, Antidepressants and Others), By Type(Acute sciatica, Chronic sciatica, and Others), By Distribution channel(Hospital pharmacies, Retail & specialty pharmacies, and Online providers), By Region - Industry Forecast 2024-2031

Global Sciatica Treatment Market size was valued at USD 705.80 million in 2022 and is poised to grow from USD 734.74 million in 2023 to USD 1013.30 million by 2031, growing at a CAGR of 4.1% in the forecast period (2024-2031).

Sciatica is a condition characterized by the radiating pain along the path of the sciatic nerve, extending from the lower back through the hips and down each leg. This discomfort often arises when factors such as a herniated disk, spinal bone spur, or spinal stenosis compress a part of the sciatic nerve, triggering inflammation and causing symptoms such as pain, numbness, tingling, or weakness in the affected leg. The prevalence of sciatica has observed a notable increase in recent years, driven by various contributing factors.  

Sedentary lifestyles, a heightened prevalence of obesity, and an aging population have played significant roles in the surge of sciatica cases. Additionally, advancements in diagnostic technologies have enhanced the accuracy of sciatica diagnosis, leading to a greater number of reported instances. According to a study by MMR, approximately 40% of individuals experience sciatica at some point in their lives, with a higher occurrence during the 40s and 50s, and a more frequent impact on men compared to women.